Weighted Average Number of Shares Outstanding, Diluted of Semnur Pharmaceuticals, Inc. from 30 Sep 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Semnur Pharmaceuticals, Inc. annual and quarterly Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2024 to 31 Dec 2025.
  • Semnur Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 201,686,617, a 0.84% increase year-over-year.
  • Semnur Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 204,784,615, a 2.4% increase from 2024.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

Semnur Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 204,784,615 +4,784,615 +2.4% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 200,000,000 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY

Semnur Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 201,686,617 +1,686,617 +0.84% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q3 2024 200,000,000 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.